Jove
Visualize
联系我们

相关概念视频

Dialysis01:27

Dialysis

286
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
286
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

77
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
77
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

355
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
355
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

69
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
69
Renal Drug Excretion: Tubular Reabsorption01:25

Renal Drug Excretion: Tubular Reabsorption

144
Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
144
Drug Elimination by Renal Route: Tubular Reabsorption01:22

Drug Elimination by Renal Route: Tubular Reabsorption

3.3K
During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
3.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Kidney supportive care in Australia and New Zealand: an ANZSN and ANZSPM guidance document.

Internal medicine journal·2026
Same author

Auditing Cause of Death Reporting to Australia and New Zealand's Dialysis and Transplant Registry: A Retrospective Cohort Study.

Nephrology (Carlton, Vic.)·2025
Same author

Factors associated with quality of life in patients with kidney failure managed conservatively and with dialysis: a cross-sectional study.

BMC nephrology·2023
Same author

Quality of Life in Patients with Chronic Kidney Disease Managed with or without Dialysis: An Observational Study.

Kidney360·2022
Same author

End-stage kidney disease: The last 12 months.

Australian journal of general practice·2021
Same author

Factors Influencing Long-Term Patient and Allograft Outcomes in Elderly Kidney Transplant Recipients.

Kidney international reports·2021
Same journal

Renal Allograft Sympathetic Reinnervation and Possible Impact on Cardiovascular Risk Profile and Graft Function.

Kidney international reports·2026
Same journal

Randomized Crossover Trial of Low Sodium Dialysate on Tissue Sodium Accumulation in Hemodialysis.

Kidney international reports·2026
Same journal

Circulating Antinephrin Antibodies in Adult Chinese Patients With IgAN and Nephrotic-Range Proteinuria.

Kidney international reports·2026
Same journal

Ultrasensitive Immunoassay Using a Novel Galactose-Deficient IgA1 Antibody and Its Clinical Application in the Diagnosis of IgAN.

Kidney international reports·2026
Same journal

Association of IgG N-Glycans With Adverse Outcomes in CKD.

Kidney international reports·2026
Same journal

Urinary Soluble CD163: A Dynamic Biomarker for Monitoring Treatment Response and Relapse in IgA Nephropathy.

Kidney international reports·2026
查看所有相关文章
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jun 18, 2025

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

15.2K

透析戒断后的预后 透析戒断后的预后

Sarah So1,2, Kelly Chen Lei Li3

  • 1Department of Renal Medicine, Nepean Kidney Research Center, Nepean Hospital, Kingswood, Sydney, New South Wales, Australia.

Kidney international reports
|July 31, 2024
PubMed
概括
此摘要是机器生成的。

从透析中断后,腹膜透析的中位生存时间为4天,血液透析的中位生存时间为6天. 戒断的心理社会原因与更长的生存时间有关,有助于终身护理讨论.

关键词:
慢性脏疾病 慢性脏疾病透析 戒断 透析 戒断最终阶段的脏疾病.脏支持性护理 支持性护理支持性护理是指的支持性护理.

更多相关视频

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

2.5K
A Murine Model of Hemodialysis Access-Related Hand Dysfunction
08:39

A Murine Model of Hemodialysis Access-Related Hand Dysfunction

Published on: May 31, 2022

1.7K

相关实验视频

Last Updated: Jun 18, 2025

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

15.2K
A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

2.5K
A Murine Model of Hemodialysis Access-Related Hand Dysfunction
08:39

A Murine Model of Hemodialysis Access-Related Hand Dysfunction

Published on: May 31, 2022

1.7K

科学领域:

  • 腎臟病學 (nephrology) 是一種醫學專業.
  • 抚慰性护理是一种缓解性护理.
  • 临床预测 临床预测

背景情况:

  • 透析中断是接受脏替代疗法的患者死亡的常见原因.
  • 预后信息对于终身护理咨询至关重要,但在透析停止后是有限的.
  • 这项研究调查了透析停止后的生存时间和相关因素.

研究的目的:

  • 为了确定透析停止后的中位生存时间.
  • 为了确定患者和透析相关的因素,与戒断后的预后相关.

主要方法:

  • 一项回顾性队列研究,使用来自西部脏服务的注册表数据.
  • 包括在2016年1月1日至2022年6月30日期间退出腹膜透析 (PD) 或血液透析的成年患者.
  • 主要结局:从最后一次透析到死亡的时间.

主要成果:

  • 平均存活时间为PD (n=53) 的4天 (IQR: 3-10) 和血液透析的6天 (IQR: 2-11) (n=186),没有显著差异 (P=0.72).
  • 对于PD,戒断原因是唯一显著的因素 (P=0.01),心理社会原因与更长的生存时间有关 (P=0.002).
  • 对于血液透析,停药原因 (P=0.001),尿液产量 (P=0.005),血清 (P=0.02) 和吸烟状态 (P=0.009) 都显著.

结论:

  • 透析停止后的中位生存时间很短,心理社会原因与更长的生存时间有关.
  • 调查结果可以为临床讨论患者和家人的预后和终身规划提供信息.